Alcidion Group (ASX:ALC) - Aandelenkoers, Nieuws & Analyse

ALC Overzicht aandelen

Alcidion Group Limited houdt zich samen met haar dochterondernemingen bezig met de ontwikkeling en licentiëring van softwareproducten voor de gezondheidszorg in Australië, Nieuw-Zeeland en het Verenigd Koninkrijk.

Over het bedrijf

ALC fundamentele analyse
Sneeuwvlok Score
Waardering	6/6
Toekomstige groei	4/6
Prestaties in het verleden	0/6
Financiële gezondheid	4/6
Dividenden	0/6

Beloningen

Trading at 70.9% below our estimate of its fair value

Earnings are forecast to grow 103.74% per year

Trading at good value compared to peers and industry

Analysts in good agreement that stock price will rise by 57.2%

Risicoanalyse

Shareholders have been diluted in the past year

Does not have a meaningful market cap (A$71M)

Alcidion Group Limited Concurrenten

Mach7 Technologies

ASX:M7T

AU$101.3m

Beamtree Holdings

ASX:BMT

AU$65.2m

Enlitic

ASX:ENL

AU$35.7m

MedAdvisor

ASX:MDR

AU$137.8m

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Alcidion Group
Historische aandelenkoersen
Huidige aandelenkoers	AU$0.053
52 Week Hoogtepunt	AU$0.09
52 Week Laag	AU$0.04
Bèta	1.47
11 maand verandering	-8.62%
3 maanden verandering	-25.35%
1 Jaar Verandering	-25.35%
33 jaar verandering	-85.68%
5 jaar verandering	-74.15%
Verandering sinds IPO	-18.46%

Recent nieuws en updates

Recent updates

Alcidion Group Limited (ASX:ALC) Held Back By Insufficient Growth Even After Shares Climb 41%

Aug 16

Here's Why We're Not Too Worried About Alcidion Group's (ASX:ALC) Cash Burn Situation

Jul 24

Benign Growth For Alcidion Group Limited (ASX:ALC) Underpins Stock's 28% Plummet

Jun 14

We're Hopeful That Alcidion Group (ASX:ALC) Will Use Its Cash Wisely

Apr 24

Little Excitement Around Alcidion Group Limited's (ASX:ALC) Revenues As Shares Take 29% Pounding

Jan 30

Shareholders Will Probably Hold Off On Increasing Alcidion Group Limited's (ASX:ALC) CEO Compensation For The Time Being

Nov 13

Companies Like Alcidion Group (ASX:ALC) Can Afford To Invest In Growth

Oct 19

We're Interested To See How Alcidion Group (ASX:ALC) Uses Its Cash Hoard To Grow

Jul 17

Is There An Opportunity With Alcidion Group Limited's (ASX:ALC) 45% Undervaluation?

Jun 02

Alcidion Group Limited (ASX:ALC) Just Reported And Analysts Have Been Cutting Their Estimates

Feb 25

Rendement voor aandeelhouders

	ALC	AU Healthcare Services	AU Markt
7D	0%	5.0%	-1.1%
1Y	-25.4%	121.4%	16.1%

Rendement versus industrie: ALC underperformed the Australian Healthcare Services industry which returned 121.4% over the past year.

Rendement versus markt: ALC underperformed the Australian Market which returned 16.1% over the past year.

Prijsvolatiliteit

Is ALC's price volatile compared to industry and market?
ALC volatility
ALC Average Weekly Movement	10.0%
Healthcare Services Industry Average Movement	9.0%
Market Average Movement	8.6%
10% most volatile stocks in AU Market	17.5%
10% least volatile stocks in AU Market	3.6%

Stabiele aandelenkoers: ALC has not had significant price volatility in the past 3 months compared to the Australian market.

Volatiliteit in de loop van de tijd: ALC's weekly volatility (10%) has been stable over the past year.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
2000	145	Kate Quirke	www.alcidion.com

Alcidion Group Limited houdt zich, samen met haar dochterondernemingen, bezig met de ontwikkeling en licentiëring van gezondheidszorgsoftwareproducten in Australië, Nieuw-Zeeland en het Verenigd Koninkrijk. Het bedrijf biedt Miya Precision aan, een FHIR-platform (Fast Healthcare Interoperability Resource) dat digitale patiëntenzorgdiensten integreert, zoals een ondersteuningssysteem voor klinische beslissingen, een elektronisch patiëntendossier (EPD) en patiëntadministratiesystemen (PAS). Het platform biedt ook elektronische reisborden voor patiëntenstromen; virtuele zorg en beheer van patiënten op afstand; geïntegreerd zorgsysteem smart operations center; spoedeisende hulp en gespecialiseerde zorg; real-time gegevensintegratie, op FHIR gebaseerde interoperabiliteit en voorspellende analyses; uitgebreid gezondheidsdossier voor geïnformeerde patiëntenzorg; modern modulair EPD; en gestroomlijnde klinische workflows, intelligente communicatie en mobiliteitsoplossingen.

Alcidion Group Limited Samenvatting

Hoe verhouden de winst en inkomsten van Alcidion Group zich tot de beurswaarde?
ALC fundamentele statistieken
Marktkapitalisatie	AU$71.18m
Inkomsten(TTM)	-AU$8.42m
Inkomsten(TTM)	AU$37.06m

1.9x

P/S-verhouding

-8.5x

Koers/Winstverhouding

Is ALC overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
ALC resultatenrekening (TTM)
Inkomsten	AU$37.06m
Kosten van inkomsten	AU$5.14m
Brutowinst	AU$31.92m
Overige uitgaven	AU$40.34m
Inkomsten	-AU$8.42m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	-0.0063
Brutomarge	86.14%
Nettowinstmarge	-22.71%
Schuld/Eigen Vermogen Verhouding	0%

Hoe presteerde ALC op de lange termijn?

Bekijk historische prestaties en vergelijking

ALC Overzicht aandelen

Beloningen

Risicoanalyse

Alcidion Group Limited Concurrenten

ASX:M7T

AU$101.3m

ASX:BMT

AU$65.2m

ASX:ENL

AU$35.7m

ASX:MDR

AU$137.8m

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Alcidion Group Limited Announces Change of Company Secretary

Insufficient new directors

Alcidion Group Limited, Annual General Meeting, Oct 23, 2024

Full year 2024 earnings: EPS and revenues miss analyst expectations

Consensus revenue estimates fall by 15%

Alcidion Group Limited Announces Board and Committee Changes

Recent updates

Alcidion Group Limited Announces Change of Company Secretary

Insufficient new directors

Alcidion Group Limited, Annual General Meeting, Oct 23, 2024

Full year 2024 earnings: EPS and revenues miss analyst expectations

Consensus revenue estimates fall by 15%

Alcidion Group Limited Announces Board and Committee Changes

Alcidion Group Limited to Report Fiscal Year 2024 Results on Aug 29, 2024

Alcidion Group Limited (ASX:ALC) Held Back By Insufficient Growth Even After Shares Climb 41%

Alcidion Group Limited to Report Q4, 2024 Results on Jul 30, 2024

Here's Why We're Not Too Worried About Alcidion Group's (ASX:ALC) Cash Burn Situation

Price target increased by 22% to AU$0.093

Forecast to breakeven in 2025

Benign Growth For Alcidion Group Limited (ASX:ALC) Underpins Stock's 28% Plummet

We're Hopeful That Alcidion Group (ASX:ALC) Will Use Its Cash Wisely

Alcidion Group Limited Provides Revenue Guidance for the Second Half of 2024

Alcidion Group Limited to Report Q3, 2024 Results on Apr 18, 2024

New minor risk - Profitability

Consensus revenue estimates fall by 12%

Alcidion Group Limited to Report First Half, 2024 Results on Feb 28, 2024

Consensus EPS estimates fall by 17%

Price target decreased by 12% to AU$0.097

Little Excitement Around Alcidion Group Limited's (ASX:ALC) Revenues As Shares Take 29% Pounding

Alcidion Group Limited to Report Q2, 2024 Results on Jan 31, 2024

Shareholders Will Probably Hold Off On Increasing Alcidion Group Limited's (ASX:ALC) CEO Compensation For The Time Being

Alcidion Group Limited has completed a Follow-on Equity Offering in the amount of AUD 5.025 million.

New minor risk - Shareholder dilution

Alcidion Group Limited has filed a Follow-on Equity Offering in the amount of AUD 1 million.

Consensus EPS estimates fall by 315%

Price target decreased by 15% to AU$0.14

Alcidion Group Limited to Report Q1, 2024 Results on Oct 31, 2023

Companies Like Alcidion Group (ASX:ALC) Can Afford To Invest In Growth

Alcidion Group Limited, Annual General Meeting, Nov 20, 2023

Consensus EPS estimates fall from profit to AU$0.0003 loss

Now 25% undervalued

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Alcidion Group Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

Consensus EPS estimates upgraded to AU$0.0031 loss

Alcidion Group Limited to Report Q4, 2023 Results on Jul 27, 2023

Now 21% undervalued after recent price drop

We're Interested To See How Alcidion Group (ASX:ALC) Uses Its Cash Hoard To Grow

Price target decreased by 17% to AU$0.17

Is There An Opportunity With Alcidion Group Limited's (ASX:ALC) 45% Undervaluation?

Independent Non-Executive Director recently bought AU$55k worth of stock

Forecast breakeven date moved forward to 2023

Forecast breakeven date pushed back to 2024

Alcidion Group Limited (ASX:ALC) Just Reported And Analysts Have Been Cutting Their Estimates

First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.006 loss in 1H 2022)

Alcidion Group Limited to Report First Half, 2023 Results on Feb 24, 2023

Alcidion Group Limited to Report First Half, 2023 Results on Jan 30, 2023

Now 22% undervalued

Price target increased to AU$0.20

When Should You Buy Alcidion Group Limited (ASX:ALC)?

Alcidion Group Limited Announces Malcolm Pradhan Stepping Down as Executive Director and Chief Medical Officer

Alcidion Group Limited to Report Q1, 2023 Results on Oct 31, 2022

Full year 2022 earnings released: AU$0.004 loss per share (vs AU$0.002 loss in FY 2021)

Alcidion Group Limited, Annual General Meeting, Oct 25, 2022

Alcidion Group Limited to Report Fiscal Year 2022 Results on Aug 30, 2022

Alcidion Group Limited to Report Q4, 2022 Results on Jul 27, 2022

Price target decreased to AU$0.32